Paid Clinical Trials in Vancouver, WA
As of August 2026, 83 paid clinical trials are recruiting in Vancouver, Washington. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Vancouver offers studies at sites including PeaceHealth Southwest Medical Center for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Carcinoma, Non-Small-Cell Lung, Malignant Solid Neoplasm, Non-Small Cell Lung Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Vancouver
Trials by drug in Vancouver
Filter results
Newly added in Vancouver
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
82 clinical trials
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Assessment of CCM in HF With Higher Ejection Fraction
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
CCM OPEN HF Registry
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
Autologous Hair Follicle Derived Secretome as Adjunct to Aesthetic Procedures
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
MYLUNG Consortium Part 3: Observational Study
Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Family Communications After Genetic Testing
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Top Research Study Locations in Vancouver
Researchers run research studies in Vancouver, WA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| PeaceHealth Southwest Medical Center | Malignant Solid Neoplasm, Prostate Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 | 30 |
| Legacy Salmon Creek Hospital | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 15 |
| Legacy Cancer Institute Medical Oncology and Day Treatment | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 11 |
| Northwest Cancer Specialists, P.C. | Carcinoma, Non-Small-Cell Lung, Advanced Non-Small Cell Lung Cancer, Advanced Renal Cell Carcinoma | 7 |
| Northwest Cancer Specialists | Breast Cancer, HER2-positive Breast Cancer, PDAC | 3 |
| The Vancouver Clinic Inc. P.S. | Ulcerative Colitis, Crohn's Disease | 3 |
| Northwest Cancer Specialist, Pc(Us Oncology Research) | B Cell Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma | 2 |
| The Vancouver Clinic | Diabetes Mellitus, Type 2, Moderately to Severely Active Crohns Disease | 2 |
| Northwest Cancer Specialists (Compass Oncology) | Lymphoma, Large B-Cell, Diffuse, Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms | 2 |
| AG Aesthetic Centre | Post Procedural Erythema | 1 |
| Allen Gabriel MD | Capsular Contracture Associated With Breast Implant, Capsular Contracture Grade III, Capsular Contracture Grade IV | 1 |
| Clinical Study Site | Non-Small Cell Lung Cancer | 1 |
| Compass Oncology | Anaplastic Lymphoma Kinase-positive, Non-small Cell Lung Cancer | 1 |
| Legacy Salmon Creek Medical Center | Breast Cancer - Infiltrating Ductal Carcinoma, HER-2 Positive Breast Cancer | 1 |
| Local Institution - 0143 | Follicular Lymphoma | 1 |
| Molecular Testing Labs | Neisseria Gonorrheae Infection | 1 |
| Northwest Cancer Center | Oropharyngeal Carcinoma (OPC) | 1 |
| Northwest Cancer Specialists - Vancouver | Non-Small Cell Lung Cancer | 1 |
| Northwest Cancer Specialists PC | Carcinoma, Non-Small-Cell Lung | 1 |
| Northwest Cancer Specialists, P.C.-Vancouver | Extensive Stage-small Cell Lung Cancer | 1 |
| Peace Health | Diastolic Heart Failure, Heart Failure, Heart Failure With Mid Range Ejection Fraction | 1 |
| The Vancouver Clinic Inc. | Lumbar Spinal Stenosis | 1 |
| USO - Northwest Cancer Specialists | Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis | 1 |
| USOR - NW Cancer Specs P.C. | Endometrial Cancer, Recurrent or Progressive Endometrial Cancer | 1 |
| USOR - Northwest Cancer Specialists, P.C. dba Compass Oncology - Vancouver Cancer Center | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
Active & Upcoming Studies in Vancouver (2026)
Recruiting trials in Vancouver grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (60 active studies)
- A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma · Phase 3 · Corbus Pharmaceuticals Inc.
- Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma · Phase 3 · Immuneering Corporation
Cardiovascular (2 active studies)
- CCM OPEN HF Registry · Impulse Dynamics
- Assessment of CCM in HF With Higher Ejection Fraction · Impulse Dynamics
Diabetes & metabolic (1 active study)
Common conditions studied in Vancouver
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Carcinoma, Non-Small-Cell Lung (4 active studies)
- Malignant Solid Neoplasm (4 active studies)
- Non-Small Cell Lung Cancer (4 active studies)
- Advanced Non-Small Cell Lung Cancer (2 active studies)
- Anatomic Stage I Breast Cancer AJCC v8 (2 active studies)
Leading research sponsors in Vancouver
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- ECOG-ACRIN Cancer Research Group
- NRG Oncology
- National Cancer Institute (NCI)
Frequently asked questions
How many paid clinical trials are currently recruiting in Vancouver?
There are approximately 83 recruiting clinical trials in Vancouver, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Vancouver pay participants?
Most recruiting trials in Vancouver compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Vancouver?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Vancouver?
The most common conditions under active study in Vancouver include Anatomic Stage II Breast Cancer AJCC v8 (4), Carcinoma, Non-Small-Cell Lung (4), Malignant Solid Neoplasm (4), Non-Small Cell Lung Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Vancouver?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Vancouver on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Vancouver?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Vancouver?
Recruiting research sites in Vancouver include PeaceHealth Southwest Medical Center, Legacy Salmon Creek Hospital, Legacy Cancer Institute Medical Oncology and Day Treatment, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Vancouver right now?
The largest active categories in Vancouver are Cancer & tumors (60), Cardiovascular (2), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.